OncoSec Medical Inc (ONCSQ)

[Titan V]

I understand. Why I personally believe so is because PD mentioned quite a few times on the Analyst day video that they will be looking for non-dilutive funding for the registration trial (although he did say he couldn't promise on one instance). Some VC fund has been investing $10M+ a year in ONCS since so 2014 PD must have some credibility to make that possible. Hence I trust him when he says so.

A relatively worst case scenario (but not really) would be Merck only paying for the cost of Keytruda. Still not bad if ONCS can get good interim results by mid 2018 IMO.

Let's say for a moment the registration trial is a success. Merck will fully step in then, IMO. Again, PD has said quite a few times that they have no intention of going to market alone and I trust him when he says that. Anyway, after success in melanoma, do you think Merck will wait for ONCS to take another 2 years for an additional indication and so on? I don't think so. I think FDA approval in melanoma combo will open the floodgates to multiple combo trials which ONCS will not be able to manage on its own. That's when the real reward may come in for investors, either through a buyout or a bigger collaboration. Of course the registration trial will need to produce statistically significant results. Hence the risk.